Company news
Tyra Biosciences, Inc. news in 2024
Tyra Biosciences, Inc.'s news releases, calls and decks from 2024, newest first.
Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights
November 6, 2024
Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Pediatric Achondroplasia (BEACH301)
October 27, 2024
Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC)
October 23, 2024
Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET
October 22, 2024
Tyra Biosciences Announces Late-Breaking Oral Presentation on Preliminary Safety and Anti-Tumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024)
October 10, 2024
Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference
September 10, 2024
Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer
September 9, 2024
Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights
August 6, 2024
Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH)
July 1, 2024
Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights
May 8, 2024
Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors
May 6, 2024
Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
March 18, 2024
Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference
February 6, 2024
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
February 1, 2024
Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia
January 31, 2024
Decks in 2024
- Corporate Update (October 2024)
Corporate update · 38 slides · Oct 25, 2024